| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2222.1999.00535.X |
| P698 | PubMed publication ID | 10202356 |
| P2093 | author name string | MacLeod JD | |
| P2860 | cites work | Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis | Q35298118 |
| A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis | Q37306385 | ||
| Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis | Q39490863 | ||
| Comparative therapeutic studies with Tilavist | Q40547430 | ||
| The eosinophil and the eye. | Q40658388 | ||
| Therapeutic options in ocular allergic disease | Q40923051 | ||
| Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis | Q44969608 | ||
| Inhibitory effects of lodoxamide on eosinophil activation | Q47888369 | ||
| P433 | issue | 4 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 436-438 | |
| P577 | publication date | 1999-04-01 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | The treatment of allergic eye disease: has sodium cromoglycate had its day? | |
| P478 | volume | 29 |
| Q34291324 | Management of seasonal allergic conjunctivitis (SAC): current therapeutic strategies | cites work | P2860 |
Search more.